CORRESP 1 filename1.htm ndra_corresp
ENDRA Life Sciences Inc.
3600 Green Court, Suite 350
Ann Arbor, MI 48105
April 29, 2021
Securities and Exchange Commission
100 F Street, N.E. 
Washington, D.C. 20549
Attention: Irene Paik
ENDRA Life Sciences Inc.
Registration Statement on Form S-3
Filed March 25, 2021
File No. 333-254711
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, registrant ENDRA Life Sciences Inc. hereby respectfully requests that the above-referenced Registration Statement on Form S-3 be declared effective at 4:15 p.m., Eastern Time, on Monday, May 3, 2021, or as soon thereafter as is practicable.
Please direct any questions regarding this request to Mark Busch of K&L Gates LLP ((704) 331-7440; In addition, please notify Mr. Busch when this request for acceleration has been granted.
/s/ Francois Michelon
Francois Michelon
Chief Executive Officer and Director